Click me

RiGOR: Registry in Glaucoma Outcomes Research

RIGOR: Registry in Glaucoma Outcomes Research A prospective observational study comparing the effectiveness of treatment strategies for open-angle glaucoma By 2050: Open-angle glaucoma (OAG) is a lifelong, degenerative eye disease. It contributes to progressive damage of the optic nerve leading to vision loss and blindness in some individuals. Patients with OAG are on the rise because of demographics. 2.71 MILLION 7.32 MILLION PEOPLE had primary open-angle glaucoma in the U.S. in 2011, according to estimates. are expected to suffer from POAG Through the lens of OAG: RIGOR study doctors assessed OAG patients who were on a current course of therapy: 55% Females 71.9% White 91.7% Non-Hispanic ethnicity 23-97 Age range (mean age 68) Study Participants: 2,597 Majority: PATIENTS 45 Community & academic practices throughout the U.S. African-American race represented 21.5% of total enrolled patients One eye per patient Hispanic or Latino ethnicity represented 8.3% of total enrolled population For primary open-angle glaucoma (POAG), race/ethnicity is an important risk factor. African-American and Hispanic/Latino patients entered the study with poorer visual acuity and more severe stage of glaucoma than non-Hispanic white patients. PREVALENCE OF POAG: OAG PREVALENCE RATE: Rates for Hispanic Americans of Mexican heritage are similar GENERAL 7% LATINOS 6.4% POPULATION to African Americans and NON-HISPANICA WHITES AFRICAN 5.6% 5.6% HIGHER AMERICANS than non-Hispanic whites. WHITES 1.7% African-American and Hispanic/Latino patients entered into the study at greater disease severity levels than the non-Hispanic white population. Patients on the Glaucoma Severity Scale IMILD I MODERATE I SEVERE I INDETERMINATE SEVERITY (Based on the physician's assessment of the status of the optic nerve and the visual field) AFRICAN-AMERICANS: HISPANIC/LATINOS: WHITES: 6.5% 7.4% 5.9% 25% 33% 27% 36% 32% 31% BLINDNESS IS SIX TIMES MORE PREVALENT for 36% African-Americans than for whites. 28% 31% CONCLUSION: African-Americans and Hispanic/Latinos are at risk for greater disease progression. AMERICAN ACADEMY OF OPHTHALMOLOGY Funded by the Agency for Healthcare Research and Quality, Rockville, MD, Protocol Number DECIDE-10-049.R1 AHRQ Agency for Haathcare Research and Qualty Ahancing Eroeence in Hean Carewww.ahgov The Eye M.D. Association

RiGOR: Registry in Glaucoma Outcomes Research

shared by visually on Jul 16
The RiGOR study was designed to assess the comparative effectiveness of medications, laser trabeculoplasty and incisional surgery in the management of open angle glaucoma (OAG)-treated patients in the...


Unknown. Add a source


Did you work on this visual? Claim credit!

Get a Quote

Embed Code

For hosted site:

Click the code to copy


Click the code to copy
Customize size